Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.
Rosati G, Galli F, Cantore M, Bergamo F, Banzi M, Zampino MG, Mattioli R, Cardellino GG, Ronzoni M, Di Bartolomeo M, Tamberi S, Marchetti P, Rimassa L, Corsi D, Bochicchio AM, Artioli F, Labianca R, Galli F, Rulli E, Bilancia D, Bregni G; TOSCA (Three or Six Colon Adjuvant) Investigators.
Rosati G, et al. Among authors: bochicchio am.
Oncologist. 2020 Jun;25(6):e928-e935. doi: 10.1634/theoncologist.2019-0736. Epub 2020 Jan 13.
Oncologist. 2020.
PMID: 31943506
Free PMC article.
Clinical Trial.